论文部分内容阅读
宫颈鳞癌肿瘤相关抗原(TA-4)首先由 kato 和 Torigoe 报道。最近已趋向将 TA-4测定应用于临床对疾病的估价。本文系对经手术和/或化疗的宫颈鳞癌患者,作动态 TA-4值测定,以观察其对肿瘤诊断和疗效的生化监测限度及其价值。另从 TA-4对宫颈鳞癌免疫组化定位,探讨它与疾病组织形态特征之间的关系。资料和方法病例为73例宫颈鳞癌,5例子宫腺癌,4例卵巢癌和10例良性妇科肿瘤(子宫肌瘤、卵
Cervical squamous cell carcinoma-associated antigen (TA-4) was first reported by Kato and Torigoe. Recently, the TA-4 assay has been used to assess the clinical value of the disease. In this paper, the dynamic TA-4 values of patients with cervical squamous carcinoma after surgery and / or chemotherapy were measured to observe the limits and their value of biochemical monitoring of tumor diagnosis and treatment. The other from TA-4 on cervical squamous cell carcinoma immunohistochemical localization, explore its relationship with the morphological characteristics of the disease. Materials and Methods 73 cases of cervical squamous cell carcinoma, 5 cases of adenocarcinoma of the uterus, 4 cases of ovarian cancer and 10 cases of benign gynecologic tumors (uterine fibroids, eggs